Skip to main content

Table 2 Acute kidney injury risk indicated by these biomarkers in septic patients analyzed by using logistic regression with generalized estimating equations

From: Diagnostic value of neutrophil gelatinase-associated lipocalin, cystatin C, and soluble triggering receptor expressed on myeloid cells-1 in critically ill patients with sepsis-associated acute kidney injury

Variable

Crude: model 1a

Adjusted: model 2b

Adjusted: model 3c

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

Plasma NGAL

1.013 (1.010-1.015)

<0.001

1.012 (1.009-1.014)

<0.001

1.013 (1.010-1.022)

<0.001

Urine NGAL

1.030 (1.014-1.047)

<0.001

1.029 (1.014-1.045)

<0.001

1.027 (1.011-1.044)

0.001

Plasma Cys-Cd

1.003 (1.002-1.004)

0.001

1.003 (1.002-1.003)

0.001

1.003 (1.002-1.003)

<0,001

Urine Cys-Cd

1.010 (1.005-1.014)

<0.001

1.024 (1.018-1.038)

<0.001

1.022 (1.008-1.035)

0.001

Plasma sTREM-1

1.029 (1.021-1.037)

<0.001

1.023(1.016-1.031)

<0.001

1.028(1.018-1.037)

<0.001

Urine sTREM-1

1.038(1.019-1/057

<0.001

1.033(1.016-1.050

<0.001

1.031(1.009-1.053)

0.005

  1. aNot adjusted. bAdjusted for serum creatinine (SCr). cAdjusted for mean arterial pressure, Acute Physiology and Chronic Health Evaluation II scores, Sequential Organ Failure Assessment scores, and procalcitonin in addition to SCr. dOdds ratio (ORs) represent the increase in risk per 0.001 mg/L increase in cystatin C (Cys-C). CI, confidence interval; NGAL, neutrophil gelatinase-associated lipocalin; sTREM-1, soluble triggering receptor expressed on myeloid cells-1.